A376900 Stock Overview

A biotechnology company, provides hyper-personalized organ regenerative healthcare solutions in South Korea. More details

A376900 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Shares are highly illiquid

Negative shareholders equity

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

ROKIT HEALTHCARE Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for ROKIT HEALTHCARE
Historical stock prices
Current Share Price	₩18,920.00
52 Week High	₩23,700.00
52 Week Low	₩14,560.00
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	28.27%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	A376900	KR Pharmaceuticals	KR Market
7D	21.6%	1.1%	-0.4%
1Y	n/a	-5.2%	-7.4%

Return vs Industry: Insufficient data to determine how A376900 performed against the KR Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how A376900 performed against the KR Market.

Price Volatility

Is A376900's price volatile compared to industry and market?
A376900 volatility
A376900 Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	4.9%
Market Average Movement	6.2%
10% most volatile stocks in KR Market	12.6%
10% least volatile stocks in KR Market	3.0%

Stable Share Price: A376900's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: Insufficient data to determine A376900's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2012	65	Seok-hwan Yoo	rokithealthcare.com

ROKIT HEALTHCARE Inc., a biotechnology company, provides hyper-personalized organ regenerative healthcare solutions in South Korea. The company offers skin regeneration therapy for the treatment of diabetic foot ulcer; cartilage regeneration delivers hyper-personalized therapeutic solutions for osteoarthritis patients; and kidney regeneration, a hyper-personalized treatment for chronic kidney disease (CKD). It also provides bioprinters; bioinks; Huma Media, a human adult stem cell culture media; HumaTein, a human cell derived whole extracellular matrix; EpiTem, a reconstructed human epidermis model; and anti-aging supplements, as well as operates tissue bank.

ROKIT HEALTHCARE Inc. Fundamentals Summary

How do ROKIT HEALTHCARE's earnings and revenue compare to its market cap?
A376900 fundamental statistics
Market cap	₩182.09b
Earnings (TTM)	-₩7.65b
Revenue (TTM)	₩13.11b

13.9x

P/S Ratio

-23.8x

P/E Ratio

Is A376900 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A376900 income statement (TTM)
Revenue	₩13.11b
Cost of Revenue	₩7.15b
Gross Profit	₩5.96b
Other Expenses	₩13.61b
Earnings	-₩7.65b

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-794.40
Gross Margin	45.49%
Net Profit Margin	-58.31%
Debt/Equity Ratio	-34.2%

How did A376900 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/20 18:19
End of Day Share Price	2025/05/20 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ROKIT HEALTHCARE Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.